PRSS3 underexpression
|
Glioma
|
PRSS3 underexpression
|
Glioma
|
bevacizumab Sensitive: C3 – Early Trials
|
bevacizumab Sensitive: C3 – Early Trials
|
PRSS3 underexpression
|
SCCHN
|
PRSS3 underexpression
|
SCCHN
|
cetuximab Sensitive: C3 – Early Trials
|
cetuximab Sensitive: C3 – Early Trials
|